The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals

Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.

from Health and Science https://ift.tt/GDbpF1k
https://ift.tt/2HuBZj3
https://ift.tt/A8qNrVZ